| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249.
|
| [2] |
Li Y, Jin Y, Zhang J, et al. Regulation of the AKT signaling pathway in gastric cancer: Implications for diagnosis and treatment[J]. Oncol Lett,2017,14(4):3631-3637.
|
| [3] |
Zhang L, Wang DM, Zhang LQ, et al. CST1 promoted gastric cancer development by activating the AKT pathway[J]. Clinics,2025,80:100561.
|
| [4] |
Monstein HJ, Tiveljung A, Kraft CH, et al. Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis[J]. J Med Microbiol,2000,49(9):817-822.
|
| [5] |
Nardone G, Compare D. The human gastric microbiota:Is it time to rethink the pathogenesis of stomach diseases?[J]. United European Gastroenterol J,2015,3(4):255-260.
|
| [6] |
Hu YL, Pang W, Huang Y, et al. The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics[J]. Front Cell Infect Microbiol,2018,8:433.
|
| [7] |
Vinasco K, Mitchell HM, Kaakoush NO, et al. Microbial carcinogenesis: Lactic acid bacteria in gastric cancer[J]. Biochim Biophys Acta Rev Cancer,2019,1872(2):188309.
|
| [8] |
San-Millán I, Brooks GA. Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect[J]. Carcinogenesis,2017,38(2):119-133.
|
| [9] |
Coker OO, Dai Z, Nie Y, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis[J]. Gut,2018,67(6):1024-1032.
|
| [10] |
Zhong M, Xiong Y, Zhao J, et al. Candida albicans disorder is associated with gastric carcinogenesis[J]. Theranostics,2021,11(10):4945-4956.
|
| [11] |
崔玉峰, 林毅军, 王志民. 幽门螺杆菌分子检测技术研究进展[J/CD]. 中华实验和临床感染病杂志(电子版),2024,18(5):257-262.
|
| [12] |
Thrastardottir TO, Copeland VJ, Constantinou C. The association between the gut microbiome, nutritional habits, antibiotics, and gastric cancer: A scoping review[J]. Curr Nutr Rep,2022,11(1):19-38.
|
| [13] |
Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2016,27(Suppl 5):v38-v49.
|
| [14] |
Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA-positive or CagA-negative Helicobacter pylori infection[J]. Gut,1997,40(3):297-301.
|
| [15] |
Ansari S, Yamaoka Y. Helicobacter pylori virulence factor cytotoxin-associated gene A (CagA)-mediated gastric pathogenicity[J]. Int J Mol Sci,2020,21(19):7430.
|
| [16] |
Brandt S, Kwok T, Hartig R, et al. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein[J]. Proc Natl Acad Sci USA,2005,102(26):9300-9305.
|
| [17] |
Holokai L, Chakrabarti J, Broda T, et al. Increased programmed death-ligand 1 is an early epithelial cell response to Helicobacter pylori Infection[J]. PLoS Pathog,2019,15(7):e1007468.
|
| [18] |
李梦声, 韩中博. 胃癌的高危可控因素--幽门螺杆菌感染[J/CD]. 中华实验和临床感染病杂志(电子版),2023,17(3):145-150.
|
| [19] |
Mason KL, Erb Downward JR, Falkowski NR, et al. Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis[J]. Infect Immun,2012,80(1):150-158.
|
| [20] |
Faubert B, Li KY, Cai L, et al. Lactate metabolism in human lung tumors[J]. Cell,2017,171(2):358-371.
|
| [21] |
Lohse MB, Gulati M, Johnson AD, et al. Development and regulation of single-and multi-species Candida albicans biofilms[J]. Nat Rev Microbiol,2018,16(1):19-31
|
| [22] |
Nasr R, Shamseddine A, Mukherji D, et al. The crosstalk between microbiome and immune response in gastric cancer[J]. Int J Mol Sci,2020,21(18):6586.
|
| [23] |
Dohlman AB, Klug J, Mesko M, et al. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors[J]. Cell,2022,185(20):3807-3822.
|
| [24] |
Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, et al. Candida albicans and cancer: can this yeast induce cancer development or progression?[J]. Crit Rev Microbiol,2016,42(3):181-193.
|
| [25] |
Gong YB, Zheng JL, Jin B, et al. Particular Candida albicans strains in the digestive tract of dyspeptic patients, identified by multilocus sequence typing[J]. PLoS One,2012,7(7):e35311.
|
| [26] |
Yu D, Liu Z. The research progress in the interaction between Candida albicans and cancers[J]. Front Microbiol,2022,13:988734.
|
| [27] |
Kim H, Choi H, Lee SK. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD[J]. Cancer Lett,2015,356(2):733-742.
|
| [28] |
Iizasa H, Nanbo A, Nishikawa J, et al. Epstein-Barr Virus (EBV)-associated gastric carcinoma[J]. Viruses,2012,4(12):3420-3439.
|
| [29] |
Derosa L, Routy B, Fidelle M, et al. Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients[J]. Eur Urol,2020,78(2):195-206.
|
| [30] |
Jin J, Hu C, Wang P, et al. Latent infection of human cytomegalovirus is associated with the development of gastric cancer[J]. Oncol Lett, 2014,8(2):898-904.
|
| [31] |
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma[J]. Nature,2014,513(7517):202-209.
|
| [32] |
Fu K, Cheung AHK, Wong CC, et al. Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice[J]. Cell,2024,187(4):882-896. e17.
|
| [33] |
Wang L, Xin Y, Zhou J, et al. Bacterial overgrowth and diversification of microbiota in gastric cancer[J]. Eur J Gastroenterol Hepatol,2016,28(3):261-266.
|
| [34] |
Lehr K, Nikitina D, Vilchez-Vargas R, et al. Microbial composition of tumorous and adjacent gastric tissue is associated with prognosis of gastric cancer[J]. Sci Rep,2023,13(1):4640.
|
| [35] |
Liu C, Ng SK, Ding Y, et al. Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis[J]. Oncogene,2022,41(35):5144-5156.
|
| [36] |
Olekhnovich EI, Manolov AI, Samoilov AE, et al. Shifts in the human gut microbiotastructure caused by quadruple Helicobacter pylori eradication therapy[J]. Front Microbiol,2019,10:1902.
|
| [37] |
Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention[J]. Nat Rev Clin Oncol,2023,20(5):338-349.
|
| [38] |
Zhao Y, Deng X, Song Q, et al. Genetic polymorphisms in Helicobacter pylori-related genes and gastric cancer risk: A Meta-analysis[J]. Cancer Lett,2013,337(2):160-166.
|
| [39] |
Liu X, Choi MG, Kim K, et al. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features[J]. Pathol Res Pract,2020,216(12):152881.
|
| [40] |
Picca A, Ponziani FR, Calvani R, et al. Gut microbial, inflammatory and metabolic signatures in older people with physical frailty and sarcopenia: results from the BIOSPHERE study[J]. Nutrients,2019,12:65.
|
| [41] |
Oster P, Vaillant L, Riva E, et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies[J]. Gut,2022,71(3):457-466.
|
| [42] |
Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis[J]. Science, 2013,341(6145):569-573.
|
| [43] |
Chen W, Liu F, Ling Z, et al. Helicobacter pylori-induced inflammation and gastric cancer: The role of Toll-like receptor 4[J]. Mol Cancer,2014,13:137.
|
| [44] |
Liu Y, Chen X, Wu Z, et al. Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression[J]. World J Gastroenterol,2018,24(18):4565.
|
| [45] |
Delgado S, Leite AMO, Ruas-Madiedo P, et al. Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis[J]. Front Microbiol,2015,5:766.
|
| [46] |
Chen Y, Chen B,Yang T, et al. Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells[J]. Cell,2017,171(2):304-317. e15.
|
| [47] |
Vétizou M, Pitt JM, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J]. Science,2015,350(6264):1079-1084.
|
| [48] |
Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota[J]. Gut,2018,67(2):226-236.
|
| [49] |
Peng Z, Cheng S, Kou Y, et al. The gut microbiome is associated with clinical response to Anti-PD-1/PD-L1 immunotherapy in gastrointestinal cancer[J]. Cancer Immunol Res,2020,8(10):1251-1261.
|
| [50] |
Wang L, Xin Y, Zhou J, et al. Gastric mucosa-associated microbial signatures of early gastric cancer[J]. Front Microbiol,2020,11:1548.
|
| [51] |
Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J]. Science,2018,359(6371):91-97.
|
| [52] |
Zheng C, Chen T, Wang Y, et al. A randomised trial of probiotics to reduce severity of physiological and microbial disorders induced by partial gastrectomy for patients with gastric cancer[J]. J Cancer,2019,10(3):568-576.
|